ArticleJournal of thoracic disease2021

Immune checkpoint inhibitors combined with chemotherapy/bevacizumab therapy for patients with advanced lung cancer and heavily treated with EGFR mutation: a retrospective analysis.

Ran Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.